Nostos Genomics offers an AI-driven variant interpretation platform called AION, designed to transform data into genomic insights for rare disease diagnostics. Their platform enables genetic testing labs to provide fast and accurate diagnoses to more patients with genetic diseases, addressing the bottleneck in genomic variant interpretation and disease-causing mutation identification.

AION automatically identifies likely pathogenic variants in less than 2 minutes and provides comprehensive reports and exportable results. The platform employs a white-box AI approach, allowing human experts to verify its predictions. It supports accurate decision-making, outperforming traditional rules-based ACMG classification by over 50%. The solution is CE-IVDR certified and GDPR compliant, ensuring regulatory and data privacy standards are met.

With a database of more than 100 regularly updated annotations, AION helps labs scale genomic sequencing operations efficiently and sustainably, focusing on complex cases and improving diagnostic yield substantially.

LinkedIn: https://www.linkedin.com/company/nostosgenomics

Job Postings: https://nostosgenomics.recruitee.com/